The First Description of Monozygotic Twin Females Discordant for the Craniofrontonasal Syndrome Phenotype and the Report of Four Novel Pathogenic Variants in the EFNB1 Gene

doi:10.21203/rs.3.rs-386853/v1

Download PDF

Research

The First Description of Monozygotic Twin Females Discordant for the Craniofrontonasal Syndrome Phenotype and the Report of Four Novel Pathogenic Variants in the EFNB1 Gene

https://doi.org/10.21203/rs.3.rs-386853/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted

You are reading this latest preprint version

Background: Craniofrontonasal syndrome (CFNS) is a rare X-linked disorder that results from pathogenic variants in the EFNB1 gene. The syndrome paradoxically presents with greater severity of the symptoms in heterozygous females than hemizygous males.

Results: Our primary finding was the description of monozygotic twins, i.e., patients 5 & 6, discordant for the CFNS phenotype. Intriguingly, patient 5 presented classical CFNS gestalt, whereas patient 6 manifested only very subtle craniofacial features, not resembling CFNS. Besides, we have expanded the mutational spectrum of the EFNB1 gene through reporting four novel pathogenic variants – p.(Trp12*), p.(Cys64Phe), p.(Tyr73Metfs*86), p.(Glu210*). All those alterations were found applying either targeted NGS of a custom gene panel or PCR followed by Sanger sequencing and evaluated using in silico predictors. Lastly, we have also expanded the CFNS phenotypic spectrum by describing in patient 3 novel features of the syndrome, such as bifid hallux, bicornuate uterus, and abnormal right ovary segmented into six parts

Conclusions: We have described the unreported so far differences of the clinical phenotype in the monozygotic twin patients 5 & 6 harbouring an identical p.(Glu210*) variant located in the EFNB1 gene. With our finding, we have pointed to an unusual phenomenon of mildly affected females with CFNS, who may not manifest features suggestive of the syndrome. Consequently, this study may be valuable for geneticists consulting patients with craniofacial disorders.

Internal Medicine

monozygosity

discordant phenotype

EFNB1

ephrin B1

coronal craniosynostosis

custom targeted next-generation sequencing

Craniofrontonasal syndrome (CFNS; MIM: 304110) is a rare X-linked disorder that inherits in a paradoxical manner, exceptionally presenting greater severity of symptoms in heterozygous females than hemizygous males (1, 2). The clinical picture in the affected females encompasses coronal craniosynostosis (CS), frontal bossing, hypertelorism, depressed nasal bridge, bifid nose, craniofacial asymmetry, downslanting palpebral fissures, frizzy and curly hair, syndactyly and longitudinally ridged fingernails. Intriguingly, many symptomatic hemizygous men show merely hypertelorism with no other congenital anomalies of major facial dysmorphism (3, 4).

Wieacker and Wieland in 2005 explained the above paradox as a cellular interference, which assumes that due to a random X-inactivation, heterozygous females are uniquely mosaic and therefore have both functional and nonfunctional ephrin-B1, a protein which is encoded by the EFNB1 gene (Wieland et al., 2004; Wieacker and Wieland, 2005). These two ephrin-B1 forms' coexistence affects the adhesion and sorting of cells, disrupting normal embryological development (6, 7). Further reports describing more severely affected males, who all were mosaic for deleterious variants in the EFNB1, strengthen the hypothesis about the described pathomechanism's biological relevance (8). However, the precise molecular explanation for this phenomenon remains not yet fully understood (7).

Cohort description

We recruited four sporadic female individuals (patients 1–4) and one familial case consisting of two female individuals (patient 5 & 6), out of whom all but one, i.e. patient 6, presented phenotypic features suggestive of CFNS.

Clinical report

We recruited six female cases who, out of whom all but one, i.e. patient 6, presented with phenotypic characteristics suggestive for CFNS. The comparison of all clinical features noted in our cohort was outlined in Table 1, whereas the photographic documentation of facial dysmorphism and hand and foot anomalies was shown in Supplementary Fig. 1. Our study's primary finding was the description of monozygotic twins, i.e., patients 5 & 6, discordant for the CFNS phenotype. Patient 5 presented with classical CFNS dysmorphia such as corse facial feature, CS and syndactyly (Fig. 1a-d), whereas patient 6 manifested only very subtle craniofacial features not resembling CFNS (Fig. 1e).

Table 1

Clinical manifestations of seven patients with craniofrontonasal syndrome. ID – intellectual disability HPO no. – Human Phenotype Ontology database number identification for phenotypic abnormality (Köhler et al., 2014); Symbols: +, feature present; (+); −, feature absent; nd, no data; na, not applicable.
#	Features	HPO no.	patient 1	patient 2	patient 3	patient 4	patient 5	patient 6
1	Variant: NM_004429.4		c.35G > A	c.191G > T	c.216del	c.451G > A	c.628G > T	c.628G > T
2	Sex		F	F	F	F	F	F
3	Relationship		na	na	na	na	Twin 1	Twin 2
4	Hypertelorism	HP:0000316	+	+	+	+	+	-
5	Epicanthus	HP:0000286	-	+	+	-	+	-
6	Down-slanting palpebral fissures	HP:0000494	Up-slanting palpebral fissures	-	up-slanting palpebral fissures	+	-	-
7	Anteverted nares	HP:0000463	+	+	+	+	+	+
8	Depressed nasal bridge	HP:0005280	+	+	prominent nasal bridge	+	+	+
9	Midline nasal groove	HP:0004112	+		+	+	+	-
10	Abnormality of the pinna	HP:0000377	+ thick helix	-	prominent antihelix	+	+	-
11	Low-set ears	HP:0000369	-	+	+	+	+	+
12	Coarse facial feature	HP:0000280	+	+	+	+	+	+
13	Midface retrusion	HP:0011800	+	+	+	+	-	-
14	Micrognathia	HP:0000347	+	-	-	+	+	+
15	High palate	HP:0000218	+	+	+	+	-	-
16	Anterior open bite	HP:0200095	+	+	+	+	-	-
17	Cleft upper lip	HP:0000204	-	-	-	-	-	-
18	Bilateral cleft lip and palate	HP:0002744	-	-	-	-	-	-
19	Ankyloglossia	HP:0010296	-	?	+	-	-	-
20	Hoarse voice	HP:0001609	-	?	+	-	*	*
21	Short neck	HP:0000470	+	+	+	+	-	+
22	Small anterior fontanelle	HP:0000237	-	?	?	?	-	-
23	Dysgenesis of the corpus callosum	HP:0006989	?		+ (posterior part)	-	?	?
24	Agenesis of the corpus callosum	HP:0001274	?	+	-	+	?	?
25	Plagiocephaly	HP:0001357	-	+	-	+	+	-
26	Craniosynostosis	HP:0001363	-	+	+	+	+	-
27	Global developmental delay	HP:0001263	+ Mild ID	-	+ Mild ID	+	-	-
28	Brachydactyly	HP:0001156	+	-	+	-	+	+
29	Broad thumb	HP:0011304	+	-	duplicated thumb	-	+	-
30	Toe syndactyly Finger syndactyly	HP:0001770 HP:0006101	-	+ (feet)	-	-	+ (feet)	-
31	Longitudinal ridging of toenails	HP:0001807	+	+	+	?	+	+
32	Longitudinal ridging of fingernails	HP:0001807	+	+	+	+	+	+
33	Shoulder girdle muscle atrophy	HP:0003724	-	+	+	?	*	*
34	Limited shoulder movement	HP:0006467	-	?	+	-	*	*
35	Low-set nipples	HP:0002562	+	+	+	-	-	-
* – the symptom cannot be assessed (the patient too young)

Patient 3 presented some novel for CFNS clinical features such as a bifid hallux (Supplementary Fig. 1d) bicornuate uterus, abnormal right ovary segmented into six parts by five serpentine-like constrictions, with the largest ovary part of 1.5 cm, while the smallest one of 0.5 cm in diameter. To our best knowledge, this phenotype has not been reported in CFNS yet. She also showed congenital horizontal nystagmus, alternating divergent strabismus, defects of the genitourinary system, including horseshoe kidney, and not noted in CFNS thus far.

Patient 5

Patient 5 was a girl born in the 38^th week of gestation from 4^th pregnancy twined to unrelated healthy parents (Figure 1f). The pregnancy history was unknown because patient 5 was adopted. Her body mass was 2370 g (<3^rd percentile), length 49 cm (<3^rd percentile), Apgar score was 8-10-10 at 1’,3' and 5'. She was referred for dysmorphic evaluation at 1^st month of age. She had a coarse face, plagiocephaly, CS, micrognathia, a small anterior fontanel, significant hypertelorism, bilateral epicanthal folds, bilateral low-set ears, flat nasal bridge, anteverted nares, and a midline crease of the nasal tip. Brachydactyly, syndactyly of toes and longitudinal ridging of a finger- and toenails were also observed. On examination at the age of 5.5 months, she presented with a weight of 6110 g (<3^rdcentile) and head circumference of 37.8 cm (<3^rdcentile).

Patient 6

Patient 6 was a girl born in the 38^th week of gestation from 4^th pregnancy twined to unrelated healthy parents (Figure 1f). The pregnancy history was unknown because patient 6 was adopted. Her body mass was 2330 g (<3^rd percentile), length 50 cm (<3^rd percentile), Apgar score was 8-8-9 at 1', 3', 5' and 10'. She was referred for dysmorphic evaluation at 4^th month of age since her twin sister obtained a diagnosis of CFND. She had coarse facial features, anteverted nares, depressed nasal bridge, short neck and longitudinal ridging of a finger- and toenails.

Targeted next-generation sequencing (NGS) and Sanger sequencing

gDNA (isolated from peripheral blood lymphocytes) of Patients 1 & 5 was subject to targeted NGS of a custom gene panel that revealed two novel heterozygous variants in the EFNB1 gene – c.35G>A p.(Trp12*) and c.628G>T p.(Glu210*), respectively (Figure 2a). The presence of both alterations was confirmed by Sanger sequencing. Patients 2-4 were screened before the advent of the NGS method. Thus the molecular diagnosis was achieved by Sanger sequencing on gDNA isolated from peripheral blood lymphocytes, which revealed the presence of the following three heterozygous alterations out of which two were novel – c.191G>T p.(Cys64Phe), c.216del p.(Tyr73Metfs*86). In contrast, one variant has been previously reported c.451G>A p.(Gly151Ser) (HGMD no: CM041297) (Figure 2b). The family history of patient 5 showed that she has a twin sister who, despite the lack of typical CFNS symptoms, underwent targeted PCR and Sanger sequencing. We evaluated the pathogenicity of missense variants in silico applying multiple online prediction tools including Polyphen-2, SIFT, CADD, MutationTaster and other resources such as DANN, FATHMM-MKL, LRT, BayesDel addAF, BayesDel noAF, GERP, PhyloP100, PhastCons integrated into either VarSome online tool or Alamut^® Visual software product. The classification of all variants was performed following the American College of Medical Genetics and Genomics (ACMG) guidelines (Table 2). Applying SWISS-MODEL, we have visualized in 3D both wild type and mutated missense alterations in the ephrin-B1, i.e. p.(Cys64Phe) and p.(Gly151Ser) (13).

Table 2

The overview of missense and nonsense variants found in the EFNB1 gene through MutationTaster, Varsome online tools (obtained on 2^th November 2020) and Alamut^® Visual software (obtained on 10^th November 2020)
	patient 1	patient 2	patient 4	patient 5 & 6
coding DNA level (NM_004429.4)	c.35G>A	c.191G>T	c.451G>A	c.628G>T
gDNA level	g.815G>A	g.9683	g.10712	g.11092
chromosomal level (GRCh38)	chrX:68829811G>A	chrX:68838679G>T	chrX:68839708G>A	chrX:68840088G>T
Protein level NM (NP_	p.Trp12Ter	p.Cys64Phe	p.Gly151Ser	p.Glu210Ter
Exon	1	2	3	4
HGMD (v15.11) no.	Not reported	Not reported	CM041297	Not reported
dbSNP rs number	rs1482772814	Not reported	rs28936069	Not reported
gnomAD (v2.1.1)	Not reported	Not reported	Not reported	Not reported
1000 Genomes	Not reported	Not reported	Not reported	Not reported
ACMG classification	Pathogenic	Likely pathogenic	Likely pathogenic	Pathogenic
SIFT (v6.2.0)	n.d.	Deleterious	Deleterious	n.d.
PolyPhen-2 (v2)	n.d.	Probably damaging	Probably damaging	n.d.
DANN (v2014)	0.9954	0.9935	0.9989	0.9969
FATHMM-MKL (dbNSFP v4.1)	Damaging	Damaging	Damaging	Damaging
LRT (dbNSFP v4.1)	Neutral	Deleterious	Deleterious	Neutral
BayesDel addAF (v4.1)	Damaging	Damaging	Damaging	Damaging
BayesDel noAF (v4.1)	Damaging	Damaging	Damaging	Damaging
MutationTaster (v2013)	Disease causing	Disease causing	Disease causing	Disease causing

Zygosity analysis

The monozigosity of twin patient 5 & 6 was confirmed based on an analysis of 33 STR markers localized on 13, 18, 21, X and Y chromosomes.

X chromosome inactivation (XCI) assay

We detected random XCI in twin patient 6 (46% vs. 54%), who manifested facial features unsuggestive for CFNS, whereas non-random XCI (84% vs. 16%) in twin patient 5, who showed a classical CFNS facial phenotype.

Face2Gene analysis

The craniofacial phenotype of patient 6 was assessed using Face2Gene online available tool. Among the suggested 30 different syndromes, CFNS was not listed by the algorithm. However, the first five proposed diagnoses were as follows – Cornelia de Lange syndrome, Costello syndrome, Megalencephaly-Capillary Malformation-Polymicrogyria Syndrome, Alpha-Thalassemia/mental Retardation Syndrome and CHARGE syndrome. On the contrary, the phenotype of patient 5 was correctly identified as CFNS (listed as second).

Although monozygotic twins originate from a single zygote and share the same genetic material and similar intrauterine environment, they occasionally may show discordant phenotypes of monozygotic disorder. The differences in clinical phenotype can be explained through at least several mechanisms such as epigenetic factors, an asymmetric split of the embryo, discordant cell differentiation or abnormalities in placental blood flow (14–16). Surprisingly, here we have diagnosed monozygotic twin patients, i. e. patient 5 & 6, who presented with highly variable severity of the CFNS symptoms. Both individuals carried the same p.(Glu210*) pathogenic EFNB1 variant and identical germline genetic information. In patient 5, we noted a typical female presentation of CFNS (Table 1, Fig. 1a-d). In contrast, in patient 6, we only detected mild facial anomalies unsuggestive for CFNS, including anteverted nares, depressed nasal bridge, low-set ears, coarse facial features, micrognathia and short neck (Table 1 and Fig. 1e). Besides, the craniofacial phenotype of patient 6 was analyzed using Face2Gene, which did not match CFNS among the possible dysmorphological diagnoses.

Mild clinical features in female individuals with CFNS are rather unusual. As mentioned before, CFNS inherits paradoxically and presents more severe clinical symptoms in females, who harbour the heterozygous EFNB1 variants in comparison to hemizygous males. Furthermore, rarely reported mosaic male individuals are more severely affected than their hemizygous counterparts. This is because other ephrin family members can presumably substitute the complete lack of ephrin-B1 in purely hemizygous males (3, 7, 17). In the medical literature, we have found merely one description of mildly affected CFNS female patient. Twigg et al. reported a familial case (family no. 3217) heterozygous for a missense pathogenic variant p.(Pro54Leu), in which one of the affected females had minimal clinical manifestations of CFNS. However, this patient was shown to have a lower mutation level in the hair roots and buccal swab (2). In our case, we were unable to check for the mosaicism in mesoderm or ectoderm-derived cell lines, although the level for the causative variant in blood cells reached 50% of reads, being unsuggestive of somatic mosaicism.

Except for mosaicism in other than blood cells, one may suspect the presence of additional modifiers of the phenotype, including epigenetic factors (18–20). To check whether the variable severity of CFNS in both twin females resulted from skewed X chromosome inactivation, we performed XCI testing. We hypothesized that similar to male patients who show minimal CFNS symptoms, our mildly affected twin sister may have a highly preferential expression of the EFNB1 from a single gene copy, resembling its status in hemizygosity. To our surprise, we demonstrated unequal XCI in the severely affected twin patient 5 (84% vs. 16%), and almost random X inactivation in the mildly affected twin patient 6 (46% vs. 54%). Our finding, therefore, suggests that skewed X inactivation cannot account for the mild presentation of CFNS in one of our twin sisters and probably other mildly affected female individuals. Recently, another research group did not find evidence for preferential XCI or a distinct correlation between XCI ratios in a group of familial X-linked hypohidrotic ectodermal dysplasia patients showing variable disease manifestation (21). Hence our result strengthens the above conclusion regarding the presence of additional yet undetected modifying factors resulting in discordant phenotype in X-linked disorders.

The second result of our study is the expansion of the EFNB1 gene mutational spectrum. Here, we have described three additional novel variants located in the EFNB1 gene – p.(Trp12*), p.(Tyr73Metfs*86), p.(Glu210*) and consequently increased the total number of CFNS-associated pathogenic variants to 123. All newly identified alterations were found applying either targeted NGS of a custom gene panel or PCR followed by Sanger sequencing. Subsequently, we evaluated the pathogenicity of the detected variants using in silico predictors (Table 2). We have also compared the phenotypic presentation of the six CFNS-affected individuals, all of whom were females (Table 1). Lastly, we have also broadened the phenotypic spectrum of CFNS syndrome, as we reported new features present in patient 3, such as a bifid hallux, bicornuate uterus and abnormal right ovary segmented into six parts.

First of all, we have pointed to an unusual phenomenon of mildly affected females with CFNS, who may not manifest features suggestive of the syndrome. As a consequence, this study may be valuable for clinical geneticists consulting patients with craniofacial disorders and who potentially may overlook such individuals. Second, we excluded skewed XCI pattern as a cause of discordant phenotype in monozygotic twins described here. Our study strengthens the recent conclusion regarding the presence of additional yet undetected modifying factors resulting in X-linked disorders' discordant phenotype. Finally, we have expanded the mutational spectrum of the EFNB1 gene by reporting three other novel pathogenic variants causing CFNS.

Targeted NGS

We designed and applied the custom On-Demand AmpliSeq (ThermoFisher Scientific) panel targeting 37 genes related to craniofacial disorders (9,10). We constructed the barcoded gDNA libraries according to the manufacturer's sample preparation protocol (Ion AmpliSeq Library Kit 2.0; On-Demand Panels) and subsequently sequenced them on the Ion Torrent S5 platform using the Ion 530™ or 540™ Chip.

PCR and Sanger sequencing

PCR followed by Sanger sequencing was used to validate variants detected through targeted NGS (patient 1 & 5) and screen the coding sequence of the EFNB1 gene (patients 2-4). Besides, we performed targeted Sanger sequencing in the twin sister of patient 6 (targeted analysis of exon 4). We designed specific primers (Supplementary Table 1) using Primer3 tool v. 0.4.0. The PCR reactions and PCR product purifications were carried out following standard protocols. Next, Sanger sequencing was performed on an automated sequencer Applied Biosystems Prism 3700 DNA Analyzer using dye-terminator chemistry kit v.3, ABI 3130XL. Finally, the variant was visualized by applying the BioEdit tool and annotated against the reference EFNB1 sequence NM_004429.4 following the Human Genome Variation Society (HGVS) nomenclature guidelines.

Zygosity test

We used Devyser Complete v2 kit (Devyser, Sweden) following the manufacturer's protocol to analyze the twin sisters zygosity status (patient 5 & 6). The kit contains 33 short tandem repeats (STR) markers localized on 13, 18, 21, X and Y chromosomes.

XCI assay

We performed XCI assay based on the methylation specificity of restriction enzymes at STR located within the AR gene (patient 5 & 6). We used HpaII restriction endonuclease that presents a particular activity only on unmethylated gDNA. 100 ng of gDNA was digested with either 20 U RsaI (reference sample) or a mixture of enzymes, i.e. 20 U RsaI and 20 U HpaII (Thermo Fisher Scientific). After incubation and inactivation of enzymes we performed PCR amplification. The reaction was set up using FAM-labeled primers 5′-TCCAGAATCTGTTCCAGAGCGTGC-3 (forward), 5′-GCTGTGAAGGTTGCTGTTCCTCAT-3 (reverse) as described by Janczar et al. (11,12). We separated the PCR products on an ABI 3130 DNA sequencing analyzer (Applied Biosystems) and analyzed in GeneMarker software v2.7.0 (SoftGenetics). The area under the peak was calculated and normalized (11).

Face2Gene analysis

We used Face2Gene tool to test whether the craniofacial symptoms present in twin patients 5 & 6 were characteristic of CFNS. Face2Gene's inbuilt algorithm quantifies facial gestalt based on hundreds of photographs of specific and confirmed syndrome patients. As a result, a list of possibly matching syndromes is created and ranked with a score called Gestalt Score.

ACMG – American College of Medical Genetics and Genomics, CFNS – craniofrontonasal syndrome, CS – craniosynostosis, NGS – next-generation sequencing, XCI – X chromosome inactivation

Availability of data and materials

The datasets for this article are not publicly available due to concerns regarding participants/ patients anonymity. Requests to access the datasets should be directed to the corresponding author.

Ethics statement

According to the Good Clinical Practice and Polish law, the studies involving human participants were reviewed and approved by the Bioethics Committee at Poznan University of Medical Sciences (no. 741/17 and 742/17). All patients and their parents agreed to participate in this study. Written informed consent to participate in this study was provided by the participants' legal guardian/next of kin. Written informed consent was obtained from the minor(s)' legal guardian/next of kin to publish any potentially identifiable images or data included in this article.

Authors' contributions

A.J., A.J.-T., M.J., E.O. recruited and clinically diagnosed the patients; A.J. and E.B.-O. designed the study and wrote the manuscript; E.B.-O. performed, analyzed the molecular data and prepared figures, and tables, P.G. performed a part of in silico analysis, M.P. and M.B. participated in a part of the experimental procedures. All authors have read and approved the final manuscript.

Funding

This work was supported by the Poznan University of Medical Sciences grant – 502-14-11261860-41259 to E.B.-O., the Polish National Science Centre grants 2016/23/N/NZ5/02577 to E.B.-O., 2016/22/E/NZ5/00270 to A.J.

Acknowledgements

We are grateful to the patients and their parents for participating in this study.

Conflict of interest

The authors declare that they have no conflict of interest.

Web resources

ClinVar, https://www.ncbi.nlm.nih.gov/clinvar/

Face2Gene, https://www.face2gene.com/

gnomAD, https://gnomad.broadinstitute.org/

HGMD, http://www.hgmd.cf.ac.uk/ac/index.php

OMIM, https://www.omim.org/

Primer3, http://bioinfo.ut.ee/primer3-0.4.0/

Varsome: https://varsome.com/

Cohen MMJ. Craniofrontonasal dysplasia. Birth Defects Orig Artic Ser. 1979;15(5B):85–9.
Twigg SRF, Matsumoto K, Kidd AMJ, Goriely A, Taylor IB, Fisher RB, et al. The origin of EFNB1 mutations in craniofrontonasal syndrome: frequent somatic mosaicism and explanation of the paucity of carrier males. Am J Hum Genet. 2006 Jun;78(6):999–1010.
Twigg SRF, Babbs C, van den Elzen MEP, Goriely A, Taylor S, McGowan SJ, et al. Cellular interference in craniofrontonasal syndrome: males mosaic for mutations in the X-linked EFNB1 gene are more severely affected than true hemizygotes. Hum Mol Genet. 2013 Apr;22(8):1654–62.
Van Den Elzen MEP, Twigg SRF, Goos JAC, Hoogeboom AJM, Van Den Ouweland AMW, Wilkie AOM, et al. Phenotypes of craniofrontonasal syndrome in patients with a pathogenic mutation in EFNB1. Eur J Hum Genet [Internet]. 2014;22(8):995–1001. Available from: http://dx.doi.org/10.1038/ejhg.2013.273
Wieacker P, Wieland I. Clinical and genetic aspects of craniofrontonasal syndrome: Towards resolving a genetic paradox. Mol Genet Metab. 2005;86(1–2):110–6.
Compagni A, Logan M, Klein R, Adams RH. Control of skeletal patterning by ephrinB1-EphB interactions. Dev Cell. 2003 Aug;5(2):217–30.
Niethamer TK, Teng T, Franco M, Du YX, Percival CJ, Bush JO. Aberrant cell segregation in the craniofacial primordium and the emergence of facial dysmorphology in craniofrontonasal syndrome. PLoS Genet. 2020 Feb;16(2):e1008300.
Shotelersuk V, Kamolvisit W, Rojvachiranonda N, Suphapeetiporn K, Porntaveetus T, Shotelersuk V. Severe craniofrontonasal syndrome in a male patient mosaic for a novel nonsense mutation in EFNB1. Eur J Med Genet. 2020 Jun;63(6):103924.
Bukowska-Olech, Ewelina; Materna-Kiryluk, Anna; Walczak-Sztulpa, Joanna; Popiel, Delfina; Badura-Stronka, Magdalena; Koczyk, Grzegorz; Dawidziuk, Adam; Jamsheer A. Targeted next-generation sequencing in the diagnosis of facial dysostoses. Front Genet. 2020;11(November):1–12.
Bukowska-Olech E, Sowińska-Seidler A, Łojek F, Popiel D, Walczak-Sztulpa J, Jamsheer A. Further phenotypic delineation of the auriculocondylar syndrome type 2 with literature review. J Appl Genet [Internet]. 2020; Available from: https://doi.org/10.1007/s13353-020-00591-3
Janczar S, Babol-Pokora K, Jatczak-Pawlik I, Taha J, Klukowska A, Laguna P, et al. Six molecular patterns leading to hemophilia A phenotype in 18 females from Poland. Thromb Res. 2020 Sep;193:9–14.
Janczar S, Kosinska J, Ploski R, Pastorczak A, Wegner O, Zalewska-Szewczyk B, et al. Haemophilia A and cardiovascular morbidity in a female SHAM syndrome carrier due to skewed X chromosome inactivation. Eur J Med Genet [Internet]. 2016;59(1):43–7. Available from: http://www.sciencedirect.com/science/article/pii/S1769721215300598
Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018 Jul;46(W1):W296–303.
Izumi K, Hayashi D, Grochowski CM, Kubota N, Nishi E, Arakawa M, et al. Discordant clinical phenotype in monozygotic twins with Alagille syndrome: Possible influence of non-genetic factors. Am J Med Genet A. 2016 Feb;170A(2):471–5.
Li L, Huang L, Lin S, Luo Y, Fang Q. Discordant phenotypes in monozygotic twins with 16p11.2 microdeletions including the SH2B1 gene. Am J Med Genet A. 2017 Aug;173(8):2284–8.
Dunkerton S, Field M, Cho V, Bertram E, Whittle B, Groves A, et al. A de novo Mutation in KMT2A (MLL) in monozygotic twins with Wiedemann-Steiner syndrome. Am J Med Genet A. 2015 Sep;167A(9):2182–7.
Wieland I, Makarov R, Reardon W, Tinschert S, Goldenberg A, Thierry P, et al. Dissecting the molecular mechanisms in craniofrontonasal syndrome: differential mRNA expression of mutant EFNB1 and the cellular mosaic. Eur J Hum Genet. 2008 Feb;16(2):184–91.
Abdellaoui A, Ehli EA, Hottenga J-J, Weber Z, Mbarek H, Willemsen G, et al. CNV Concordance in 1,097 MZ Twin Pairs. Twin Res Hum Genet Off J Int Soc Twin Stud. 2015 Feb;18(1):1–12.
Nishioka M, Bundo M, Ueda J, Yoshikawa A, Nishimura F, Sasaki T, et al. Identification of somatic mutations in monozygotic twins discordant for psychiatric disorders. npj Schizophr [Internet]. 2018;4(1):7. Available from: https://doi.org/10.1038/s41537-018-0049-5
Fan X, Ping L, Sun H, Chen Y, Wang P, Liu T, et al. Whole-Exome Sequencing of Discordant Monozygotic Twin Families for Identification of Candidate Genes for Microtia-Atresia. Front Genet. 2020;11:568052.
Körber L, Schneider H, Fleischer N, Maier-Wohlfart S. No evidence for preferential X-chromosome inactivation as the main cause of divergent phenotypes in sisters with X-linked hypohidrotic ectodermal dysplasia. Orphanet J Rare Dis. 2021 Feb;16(1):98.

SupplementaryFigure131.03.2021.tif
Additional Figure 1 Facial dysmorphism (a-c) and digit anomalies (d-f) noted in our patient patients with craniofrontonasal dysplasia (CFND). Frontal view of patient 1 (a) showing the following dysmorphic features typical of CFND: coarse facies, prominent forehead, hypertelorism, depressed nasal bridge, anteverted nares, broad and bifid nasal tip with midline nasal groove. Lateral view of patient 1 (b) showing a turricephalic shape of the skull, with flat facial profile, low-set ears, dysplastic pinnae, midface retrusion, and micrognathia. Patient 3 (c) manifested hypertelorism, up-slanted palpebral fissures, anteverted nares, prominent nasal bridge and overall impression of coarse facial features. Partial skin syndactyly of toes 2-3 was noted in patients 2 (d) and 3 (e). Patient 3 also shows bifid hallux (g) and clinodactyly of the 5th fingers (f).
SupplementaryTable1.docx
Supplementary Table 1 List of primers used for PCR and Sanger sequencing

Download PDF

Version 1

posted

You are reading this latest preprint version

The First Description of Monozygotic Twin Females Discordant for the Craniofrontonasal Syndrome Phenotype and the Report of Four Novel Pathogenic Variants in the EFNB1 Gene

Status:

Version 1

Abstract

Figures

Introduction

Results

Discussion

Conclusions

Methods

Abbreviations

Declarations

References

Supplementary Files

Status:

Version 1